{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:28:59Z","timestamp":1788881339304,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Paraneoplastic rheumatic syndromes comprise a heterogeneous group of disorders characterized by typical rheumatic manifestations but without direct invasion by the tumor or metastases. The clinical features and malignancy-associated risk factors of 21 patients with paraneoplastic rheumatic syndromes, including 11 men and 10 women with a mean age of 56.3\u2009\u00b1\u200913.1 years, were characterized by a retrospective review. All patients were diagnosed with malignancy within 2 years of rheumatism diagnosis. Patients suffering from solid malignancies accounted for the majority (62%); hematological malignancies were observed in the remainder. Arthritis (48%), lymph node enlargement (38%), skin rash (38%), weight loss (29%), fever\/chills (24%), fatigue (24%), muscle soreness (24%) and smoking history (29%) were common findings. Except for 8 patients (38%) who tested positive for anti-nuclear antibody (ANA) and 9 positive for rheumatoid factor (RF), all patients tested negative for anti-extractable nuclear antigen (ENA) antibodies. Rheumatic disorders with a typical clinical presentation in older patients and nonspecific systemic features should alert clinicians to search for an occult malignancy. Patients with rheumatic disease must be closely followed to screen for malignancies, particularly within 2 years of rheumatism diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-018-20167-w","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T14:33:39Z","timestamp":1516718019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Malignancy dominated with rheumatic manifestations: A retrospective single-center analysis"],"prefix":"10.1038","volume":"8","author":[{"given":"Jian","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"20167_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11739-017-1626-8","volume":"12","author":"M Bellan","year":"2017","unstructured":"Bellan, M. et al. Association between rheumatic diseases and cancer: results from a clinical practice cohort study. Intern Emerg Med 12, 621\u2013627 (2017).","journal-title":"Intern Emerg Med"},{"key":"20167_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.07.021","author":"B Manger","year":"2017","unstructured":"Manger, B. & Schett, G. Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity. Clinical Immunology. https:\/\/doi.org\/10.1016\/j.clim.2017.07.021 (2017).","journal-title":"Clinical Immunology"},{"key":"20167_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/kes189","volume":"52","author":"C Turesson","year":"2013","unstructured":"Turesson, C. & Matteson, E. L. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford) 52, 5\u201314 (2013).","journal-title":"Rheumatology(Oxford)"},{"key":"20167_CR4","first-page":"294","volume":"35","author":"R Solans-Laqu\u00e9","year":"2008","unstructured":"Solans-Laqu\u00e9, R. et al. Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35, 294\u2013304 (2008).","journal-title":"J Rheumatol"},{"key":"20167_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrrheum.2014.138","volume":"10","author":"B Manger","year":"2014","unstructured":"Manger, B. & Schett, G. Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol 10, 662\u2013670 (2014).","journal-title":"Nat Rev Rheumatol"},{"key":"20167_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/berh.2000.0091","volume":"14","author":"AG Fam","year":"2000","unstructured":"Fam, A. G. Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol 14, 515\u2013533 (2000).","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"20167_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00296-011-2252-9","volume":"32","author":"J Hakkou","year":"2012","unstructured":"Hakkou, J., Rostom, S., Bahiri, R. & Hajjaj-Hassouni, N. Paraneoplastic rheumatic syndromes: report of eight cases and review of literature. Rheumatol Int 32, 1485\u20131489 (2012).","journal-title":"Rheumatol Int"},{"key":"20167_CR8","first-page":"364","volume":"7","author":"V Bojinca","year":"2012","unstructured":"Bojinca, V. & Janta, I. Rheumatic diseases and malignancies. Maedica (Buchar) 7, 364\u2013371 (2012).","journal-title":"Maedica(Buchar)"},{"key":"20167_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/BOR.0b013e328359e780","volume":"25","author":"L Azar","year":"2013","unstructured":"Azar, L. & Khasnis, A. Paraneoplastic rheumatologic syndromes. Curr Opin Rheumatol 25, 44\u201349 (2013).","journal-title":"Curr Opin Rheumatol"},{"key":"20167_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.autrev.2008.02.001","volume":"7","author":"V Racanelli","year":"2008","unstructured":"Racanelli, V., Prete, M., Minoia, C., Favoino, E. & Perosa, F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 7, 352\u2013358 (2008).","journal-title":"Autoimmun Rev"},{"key":"20167_CR11","doi-asserted-by":"publisher","first-page":"e3540","DOI":"10.1097\/MD.0000000000003540","volume":"95","author":"KH Yu","year":"2016","unstructured":"Yu, K. H., Kuo, C. F., Huang, L. H., Huang, W. K. & See, L. C. Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: A nationwide population-based dynamic cohort study in Taiwan. Medicine (Baltimore) 95, e3540 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"20167_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10067-010-1676-z","volume":"30","author":"R Rugien","year":"2011","unstructured":"Rugien, R. et al. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours. Clin Rheumatol 30, 373\u2013380 (2011).","journal-title":"Clin Rheumatol"},{"key":"20167_CR13","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/1097-0142(19950615)75:12<2954::AID-CNCR2820751224>3.0.CO;2-8","volume":"75","author":"JE Naschitz","year":"1995","unstructured":"Naschitz, J. E., Yeshurun, D. & Rosner, I. Rheumatic manifestations of occult cancer. Cancer 75, 2954\u20132958 (1995).","journal-title":"Cancer"},{"key":"20167_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3109\/14397595.2013.843762","volume":"24","author":"H Yamashita","year":"2014","unstructured":"Yamashita, H. et al. Characteristics of 10 patients with paraneoplastic rheumatologic musculoskeletal manifestations. Mod. Rheumatol. 24, 492\u2013498 (2014).","journal-title":"Mod. Rheumatol."},{"key":"20167_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill, C. L. et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357, 96\u2013100 (2001).","journal-title":"Lancet"},{"key":"20167_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/030097401750065319","volume":"30","author":"G Stummvoll","year":"2001","unstructured":"Stummvoll, G., Aringer, M., Machold, K., Smolen, J. S. & Raderer, M. Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms. Report of two cases and review of the literature. Scand J Rheumatol 30, 40\u201344 (2001).","journal-title":"Scand J Rheumatol"},{"key":"20167_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13075-016-0990-5","volume":"18","author":"TA Simon","year":"2016","unstructured":"Simon, T. A., Thompson, A., Gandhi, K. K., Hochberg, M. C. & Suissa, S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 18, 100 (2016).","journal-title":"Arthritis Res Ther"},{"key":"20167_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/ard.2007.070086","volume":"67","author":"J Morel","year":"2008","unstructured":"Morel, J. et al. Characteristics and survival of 26 patients with paraneoplastic arthritis. Ann Rheum Dis 67, 244\u2013247 (2008).","journal-title":"Ann Rheum Dis"},{"key":"20167_CR19","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/s11606-008-0794-7","volume":"23","author":"M Zupancic","year":"2008","unstructured":"Zupancic, M., Annamalai, A., Brenneman, J. & Ranatunga, S. Migratory polyarthritis as a paraneoplastic syndrome. J Gen Intern Med 23, 2136\u20132139 (2008).","journal-title":"J Gen Intern Med"},{"key":"20167_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/1756-185X.12277","volume":"17","author":"B Kisacik","year":"2014","unstructured":"Kisacik, B. et al. Diagnostic dilemma of paraneoplastic arthritis: case series. Int. J. Rheum. Dis 17, 640\u2013645 (2014).","journal-title":"Int. J. Rheum. Dis"},{"key":"20167_CR21","unstructured":"Mathsson Alm L et al. The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol (2017). [Epub ahead of print]"},{"key":"20167_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3109\/14397595.2013.844386","volume":"24","author":"H Ye","year":"2014","unstructured":"Ye, H. et al. Diagnostic utility of the Elecsys anti-CCP assay in patients with rheumatoid arthritis. Mod Rheumatol 24, 580\u2013584 (2014).","journal-title":"Mod Rheumatol"},{"key":"20167_CR23","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.jaad.2010.09.732","volume":"66","author":"JO Podjasek","year":"2012","unstructured":"Podjasek, J. O., Wetter, D. A., Pittelkow, M. R. & Wada, D. A. Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009. J Am Acad Dermatol 66, e55\u201365 (2012).","journal-title":"J Am Acad Dermatol"},{"key":"20167_CR24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0000000000000009","volume":"92","author":"J Loricera","year":"2013","unstructured":"Loricera, J. et al. The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features. Medicine (Baltimore) 92, 331\u2013343 (2013).","journal-title":"Medicine (Baltimore)"},{"key":"20167_CR25","unstructured":"Chakravarty E., Genovese M. Musculoskeletal syndromes in malignancy lymphoproliferative and myeloproliferative diseases. Kelly\u2019s Textbook of Rheumatology, 7th ed (ed. Edward, D. Harris et al.) 1754\u20131768 (2016)."},{"key":"20167_CR26","first-page":"109","volume":"70","author":"A Alias","year":"2012","unstructured":"Alias, A., Rodriguez, E. J., Bateman, H. E., Sterrett, A. G. & Valeriano- Marcet, J. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastic- therapy. Bull NYU Hosp Jt Dis 70, 109\u2013114 (2012).","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"20167_CR27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1136\/ard.2010.145250","volume":"70","author":"C Heij","year":"2011","unstructured":"Heij, C. et al. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials. Ann Rheum Dis 70, 1415\u20131421 (2011).","journal-title":"Ann Rheum Dis"},{"key":"20167_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-94-007-6627-3_47","volume":"788","author":"K Zycinska","year":"2013","unstructured":"Zycinska, K., Kostrzewa-Janicka, J., Nitsch-Osuch, A. & Wardyn, K. Cancer incidence in pulmonary vasculitis. Adv Exp Med Biol 788, 349\u2013353 (2013).","journal-title":"Adv Exp Med Biol"},{"key":"20167_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5114\/reum.2015.51510","volume":"53","author":"M Jakubaszek","year":"2015","unstructured":"Jakubaszek, M., Kwiatkowska, B. & Ma\u015bli\u0144ska, M. Polymyositis and dermatomyositis as a risk of developing cancer. Reumatologia 53, 101\u2013105 (2015).","journal-title":"Reumatologia"},{"key":"20167_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","volume":"21","author":"JK Qiang","year":"2017","unstructured":"Qiang, J. K., Kim, W. B., Baibergenova, A. & Alhusayen, R. Risk of Malignancy in Dermatomyositis and Polymyositis. J Cutan Med Surg 21, 131\u2013136 (2017).","journal-title":"J Cutan Med Surg"},{"key":"20167_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/ol.2014.2661","volume":"9","author":"L Ding","year":"2015","unstructured":"Ding, L., Xiao, X. & Huang, L. Peripheral T-cell lymphoma with hypercalcemic crisis as a primary symptom accompanied by polymyositis: A case report and review of the literature. Oncol Lett 9, 231\u2013234 (2015).","journal-title":"Oncol Lett"},{"key":"20167_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","volume":"85","author":"D Stockton","year":"2001","unstructured":"Stockton, D., Doherty, V. R. & Brewster, D. H. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85, 41\u201345 (2001).","journal-title":"Br J Cancer"},{"key":"20167_CR33","first-page":"234","volume":"45","author":"SN Jowitt","year":"1991","unstructured":"Jowitt, S. N. et al. Hosp Med. Polymyositis in association with multiple myeloma 45, 234\u2013235 (1991).","journal-title":"Polymyositis in association with multiple myeloma"},{"key":"20167_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander, E. et al. Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65, 796\u2013803 (2006).","journal-title":"Ann Rheum Dis"},{"key":"20167_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","volume":"43","author":"AP Risselada","year":"2013","unstructured":"Risselada, A. P., Kruize, A. A., Johannes & Bijlsma, W. J. Clinical features distinguishing lymphoma development in primary Sjogren\u2019s syndrome\u2014A retrospective cohort study. Seminars in Arthritis and Rheumatism 43, 171\u2013177 (2013).","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"20167_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000353138","volume":"85","author":"B Tessier Cloutiera","year":"2013","unstructured":"Tessier Cloutiera, B. et al. Breast Cancer in Systemic Lupus Erythematosus. Oncology 85, 117\u2013121 (2013).","journal-title":"Oncology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20167-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20167-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20167-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:41:10Z","timestamp":1671586870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20167-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20167"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20167-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1786"}}